Results 201 to 210 of about 139,634 (224)
Risk of Gout Among Patients With Tuberculosis: A Nationwide Cohort Study in South Korea. [PDF]
Int J Rheum DisKim CY, Ha JW, Jung I, Han M, Ahn SS.
europepmc +1 more source
Targeting Hyperuricemia and NLRP3 Inflammasome in Gouty Arthritis: A Preclinical Evaluation of Allopurinol and Disulfiram Combination Therapy. [PDF]
Pharmaceuticals (Basel)Asiri YI +11 more
europepmc +1 more source
Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial. [PDF]
Front ImmunolAbdellatif A +5 more
europepmc +1 more source
The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms. [PDF]
ACR Open RheumatolSolomon DH +21 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
BMJ, 2013
Gout is a common and treatable disorder of purine metabolism. Gout typically presents as recurrent self-limiting episodes of severe inflammatory arthritis affecting the foot. In the presence of persistent hyperuricaemia, tophi, chronic synovitis, and joint damage may develop.
Doherty Michael +2 more
+6 more sources
Gout is a common and treatable disorder of purine metabolism. Gout typically presents as recurrent self-limiting episodes of severe inflammatory arthritis affecting the foot. In the presence of persistent hyperuricaemia, tophi, chronic synovitis, and joint damage may develop.
Doherty Michael +2 more
+6 more sources
Current Opinion in Rheumatology, 2004
We have reviewed the latest publications on epidemiology of gout; also there have been new insights into the regulation of the inflammation resulting from the regular interaction occurring between MSU crystals and cells in both asymptomatic and symptomatic gouty joints. Finally we review different publications of clinical interest.The incidence of gout
Eliseo, Pascual, Teresa, Pedraz
openaire +4 more sources
We have reviewed the latest publications on epidemiology of gout; also there have been new insights into the regulation of the inflammation resulting from the regular interaction occurring between MSU crystals and cells in both asymptomatic and symptomatic gouty joints. Finally we review different publications of clinical interest.The incidence of gout
Eliseo, Pascual, Teresa, Pedraz
openaire +4 more sources
Annals of Internal Medicine, 2011
This issue provides a clinical overview of gout, focusing on prevention and screening, diagnosis, and treatment. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program).
Franz H, Messerli +2 more
openaire +6 more sources
This issue provides a clinical overview of gout, focusing on prevention and screening, diagnosis, and treatment. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program).
Franz H, Messerli +2 more
openaire +6 more sources
BMJ, 2010
Gout is a common arthritis caused by deposition of monosodium urate crystals within joints after chronic hyperuricaemia. It affects 1-2% of adults in developed countries, where it is the most common inflammatory arthritis in men. Epidemiological data are consistent with a rise in prevalence of gout.
Pascal, Richette, Thomas, Bardin
openaire +4 more sources
Gout is a common arthritis caused by deposition of monosodium urate crystals within joints after chronic hyperuricaemia. It affects 1-2% of adults in developed countries, where it is the most common inflammatory arthritis in men. Epidemiological data are consistent with a rise in prevalence of gout.
Pascal, Richette, Thomas, Bardin
openaire +4 more sources
Nursing Standard, 2017
Essential facts Gout is the most common cause of inflammatory arthritis worldwide. Incidence and severity is increasing in the UK, with about 2.5% of the population affected. It can be a painful and debilitating condition, yet management continues to be poor. Inadequate information for patients is one of the key barriers to improvements in care.
openaire +2 more sources
Essential facts Gout is the most common cause of inflammatory arthritis worldwide. Incidence and severity is increasing in the UK, with about 2.5% of the population affected. It can be a painful and debilitating condition, yet management continues to be poor. Inadequate information for patients is one of the key barriers to improvements in care.
openaire +2 more sources